Vol. 44 N° 1-2 - Jan/Feb/Mar/Apr/May/Jun - 1976

PREFACE

1- Preface

Charles C. Shepard


EDITORIAL NOTE

2- Editorial Note

Olaf K. Skinsnes


PROGRAM CONTENTS

3- Program of the tenth joint leprosy research conference


PARTICIPANTS

4- Participants


ORIGINAL ARTICLE

5- Experiments for transplantable multiplication of M. lepraemurium in cell-free liquid medium

Nakamura, M.


6- Factors that influence the growth of Micobacterium lepraemurium in the nakamura's system

A. M. Ohople; J. H. Hanks


7- Attempts at growth of M. leprae in mice and observations on a case: of probable contamination with another acid-fast bacillus

Tatsuji Ogawa


8- Attempts at cultivation or: Mycobacterium leprae in cell culture

Yoshiyasu Matsuo


9- A31 cell as a host of Mycobacterium lepraemurium and Mycobacterium leprae

T. Ito; H. Nomaguchi; Y. Tanaka; K. Kohsaka; T. Mori


10- Rowth of macrophages obtained from various sources

Y. T. Chang


11- Binding of 14C-Labeled dopa by Mycobacterium leprae in vitro

K. Prabhakaran; E. B. Harris; W. F. Kirchheimer


12- Progress in the radiolabeling of Mycobacterium leprae

David J. Drutz


13- In vitro cultivation of leprosy bacilli

Olaf K. Skinsnes; Eiichi Matsuo


14- Murine leprosy infections in mouse mesenteries

Akira Yamagami


15- Multiplication of Mycobacterium leprae from large inocula in neonatally thymectomized lewis rats

A. Howard Fieldsteel; Louis Levy


16- Disseminated infection in the nine-banded armadillo (Dasypus novemcinctus) resulting from inoculation with M. leprae

Chapman H. Binford; Eleanor E. Storrs; Gerald P. Walsh


17- Quantitative aspects of leprosy in armadillos

W. F. Kirchheimer; R. M. Sanchez


18- Preparation of protein from Mycobacterium leprae, skin test responses and lymphoblast transformation in vaccinated armadillos

W.F. Kirchheimer; K. Prabhakaran; E. B. Harris; R. M. Sanchez; E. J. Shannon


19- Delayed hypersensitivity tests with Mycobacterium leprae protein in leprous and non-leprous persons

W. F. Kirchheimer


20- Cell walls of Mycobacterium leprae

Philip Draper


21- Airborne infection with Mycobacterium leprae in mice

Rees. R. J. W.; McDougall A. C.


22- The role of arthropods in the transmission of leprosy

W. F. Kirchheimer


23- Discussion: nasal infection and transmission of leprosy

R.J.W. Rees


24- Untreated leprosy: probability for shifts in Ridley-Jopling classification. development of "flares", or disappearance of clinically apparent disease

Scott G. C.; D. A. Russell; C. R. Boughton; D. R. Vincin


25- The activity of thiacetazone, thiambutosine and thiocarlide in the chemotherapy of experimental leprosy

M. J. Colston; G. R. F. Hilson


26- The effect of dihydrofolate reductase inhibitors on Mycobacterium leprae in the mouse foot pad

Robert H. Gelber; Louis Levy


27- The mode of action of clofazimine DNA binding studies

N. E. Morrison; G. M. Marley


28- Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice

C.C . Shepard


29- DDS resistance in Ethiopia - a progress report

J.M.H. Pearson; W.F. Ross; R.J.W. Rees


30- The incidence of DDS resistance in lepromatous patients in costa rica: th eir metabolic disposition of DDS

J. H. Peters; C. C.Shepard; G. R. Gordon; A. V. Rojas; D. S. Elizondo


31- Drug resistant leprosy-A comparison between proven dapsone and proven thiambutosine resistance

M. F. R. Waters; J. M. N. Pearson; R. J. W. Rees


32- M. leprae persisters after treatment with DDS and rifampicin

S. R. Pattyn; P. Dockx; M. T. Rollier; R. Rollier; F. J. Saerens


33- Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies

R.J.W. Rees; M.F.R. Waters; J.M.H. Pearson; H.S. Helmy; A.B.G. Laing


34- Experience with acedapsone (DADDS) in the therapeutic trial in New Guinea and the chemoprophylactic trial in Micronesia

D.A. Russell; R.M. Worth; G.C. Scott; D.R. Vincin; B. Jano; P. Fasal; C.C. Shepard


35- Treatment failure in leprosy

Louis Levy


36- The bactericidal effect of rifampicin on M. leprae in man a) single doses of 600, 900, and 1200 mg; and b) daily doses of 300 mg

L. Levy; C. C. Shepard; P. Fasal


37- A follow-up study of nerve lesions in leprosy during and after reaction using motor nerve conduction velocity

B. Naafs; J.M.H. Pearson; A.J.M. Baar


38- Report: Effect of rifampicin for leprosy: comparative study with several doses and intervals of administration

Masashi Namba; Seigo Hazama


39- Preliminary studies with the lymph node lymphocytes of M. leprae infected mice

Theodosia M. Welch; Louis Levy


40- The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum

J. L. Krahenbuhl; T. M. Welch; L. Levy


41- Taxonomic studies on the leprosy bacillus

J . L. Stanford; G. A. W. Rook


42- Vaccination of mice against M. leprae infection

Charles C. Shepard


43- Dermal exudate macrophages: induction in dermal chambers and response to Lymphokines

M. Goihman-Yahr; M. Ulrich; A. Noya-Lιon; A. Rojas; J. Convit


44- The selective suppression of an antibody response to a given antigen

T. Matuhasi; M. Usui; M. Minami


45- Production of anti-M. leprae antibodies in man and mice under the impairment of cell-mediated immunity

Masahiqe Abe; Fumis hige Minagawa; Yuji Yoshino; Toshiharu Ozawa; Nanako Saito; Yoshiko Osawa


46- Defective leukotaxis in patients with lepromatous leprosy

Peter A. Ward; Sandra Goralnick; Ward E. Bullock


47- Quantitative dinitrochlorobenzene (DNCB) responsivity and phytohemagglutinin (PHA) induced lymphocyte transformation in patients with lepromatous leprosy

T. H. Rea; F. Quismorio; B. Harding; G. Friou; N. Levan


48- Evaluation of cell-mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test

C. K. Job; C. J. G. Chacko; P. M. Taylor; M. Daniel; G. Jesudian


49- Cell-mediated and humoral immunity in "reversal reactions."

R.StC. Barnetson; G. Bjune; J.M.H. Pearson, G. Kronvall


50- Preliminary results on the safety and efficacy of transfer factor in leprosy

R. C. Hastings; M. J. Morales; E. J. Shannon; R. R. Jacobson


51- The WHO Program for Research on Immunology of Leprosy (IMMLEP)

H . Sansarricq; G. Torribgiani; J. Walter; R. J . W. Rees


52- Discussion: Comparative study of the 48-hour response to soluble antigens obtained from human and armadillo leprosy material in lepromatous leprosy patients and normal persons, and contacts of leprosy patients

J. Convit; M. E. Pinardi; N. Aranzazu


2024 © International Journal of Leprosy and other Mycobacterial Diseases all right reaserved GN1